Details of the Drug

General Information of Drug (ID: DMNYU4L)

Drug Name

HTI-2088

Indication

Disease Entry	ICD 11	Status	REF
Type 2 diabetes	5A11	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03203811) A Phase 1, Study to Evaluate HTI-2088 Tablet. U.S. National Institutes of Health.